How to use the formulary
- Use the search tool to find the drug or condition of interest or browse by BNF chapter using the 'Chapters' Menu at top of page.
- Formulary products may be found in one or more chapters. Click on the entry in the appropriate chapter.
- First and second choices shown where possible to assist cost-effective prescribing.
- Non-formulary products are shaded in pink and labelled non-formulary.
- APCO decisions are dated within the individual product entry.
- Hyperlinks are available to BNF, BNFc and to the Summaries of Product Characteristics.
If you have any comments or queries please email occg.medicines@nhs.net.
Key to formulary recommendations
The traffic light status offers guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
|
|
Red: Medicines which should only be prescribed in secondary care by a specialist.
|
|
|
Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.
|
|
|
Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).
|
|
|
Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.
|
|
|
Brown: Medicines which should only be prescribed in restricted circumstances.
|
|
|
Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.
|
| Non-Formulary |
Non-formulary drugs should not be prescribed. Patients who are currently on a non-formulary drug, but were started within the NHS before this formulary was published, should be able to continue treatment until they and their NHS clinician consider it appropriate to stop. If clinically appropriate patients on non-formulary drugs should be switched to drugs within the formulary.
|
Site Disclaimer
Every care has been taken in the compilation and publication of the content on our website. However, Oxfordshire Clinical Commissioning Group (and its consituent NHS members) will not be held responsible for any loss, damage or inconvenience caused as a result of any inaccuracy or error within these pages.
Members of the Public
Please note that all material in this site is aimed at healthcare professionals. Members of the public seeking advice on any medicine-related matters are encouraged to contact NHS 111 or speak with their GP, pharmacist or nurse.
External Links
Links are provided for information and convenience only. We cannot accept responsibility for the sites linked to, or the information found there. A link does not imply an endorsement of a site; likewise, not linking to a particular site does not imply lack of endorsement. Links to NHS member organisational policies or guidelines may not be accessible from all locations
Virus Protection
We cannot accept any responsibility for any loss, disruption or damage to your data or your computer system that may occur while using material derived from this website. |
